Statistical analysis showed , from baseline to the 6-month visit , a significant reduction in CFT ( P < 0.0001 ) and a significant improvement in VA only in the 0.5 % INDOM-treated group ; a global reduction of discomfort symptoms was present in both groups ( P < 0.001 ) .